The Toronto-Dominion Bank
TD
Canadian Imperial Bank of Commerce
CM
Royal Bank of Canada
RY
Bank of Nova Scotia
BNS
Bank of Montreal
BMO
(Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q3)Sep 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 54.72%-291.55K | 34.93%-286.73K | 5.89%-431.24K | -263.96%-1.72M | -172.55K | -1,529.40%-643.87K | -466.91%-440.64K | -3,350.31%-458.24K | -471.28K | 45.05K |
Net income from continuing operations | 42.07%-377.73K | 15.80%-485.03K | 21.78%-408.68K | -239.66%-2.17M | ---423.78K | -697.99%-652.07K | -104.99%-576.02K | -888.22%-522.45K | ---640.14K | ---81.71K |
Operating gains losses | -361.54%-9.94K | 159.48%9.5K | 309.20%8.85K | 24.63%13.99K | --4.36K | 871.61%3.8K | 13,462.96%3.66K | 3,962.50%2.16K | --11.22K | --391 |
Depreciation and amortization | -66.79%5.44K | -46.58%5.44K | 507.03%5.44K | 1,101.97%17.12K | ---10.34K | 1,793.53%16.38K | 22,036.96%10.18K | --896 | --1.42K | --865 |
Remuneration paid in stock | -28.96%114.03K | -10.70%128.68K | -99.68%286 | 836.23%409.82K | --15.69K | --160.51K | --144.09K | --89.54K | --43.77K | ---- |
Other non cashItems | 433.66%11.5K | ---1.77K | --1.97K | -94.78%4.22K | --2.06K | -95.95%2.15K | ---- | ---- | --80.77K | --53.15K |
Change In working capital | 80.04%-34.85K | 350.26%56.45K | -37.82%-39.11K | -56.17%13.88K | --239.46K | -341.38%-174.65K | -164.15%-22.56K | -334.50%-28.38K | --31.67K | --72.35K |
-Change in receivables | 101.33%2.79K | 253.98%70.75K | 49.26%-15.16K | 31.87%-28.99K | --256.98K | -1,230.00%-210.15K | -15,216.33%-45.95K | -8,609.33%-29.87K | ---42.55K | ---15.8K |
-Change in inventory | --0 | --0 | ---- | ---- | ---- | --64.37K | ---64.37K | ---- | ---- | ---- |
-Change in prepaid assets | 60.35%-16.84K | 2,731.80%53.07K | -131.24%-31.8K | -151.29%-49.21K | --5.15K | ---42.48K | --1.87K | ---13.75K | ---19.58K | ---- |
-Change in payables and accrued expense | -252.72%-20.8K | -178.44%-67.37K | -48.56%7.84K | -1.84%92.08K | ---22.67K | -84.55%13.62K | 142.16%85.89K | 22.49%15.24K | --93.8K | --88.15K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 54.72%-291.55K | 34.93%-286.73K | 5.89%-431.24K | -263.96%-1.72M | ---172.55K | -1,529.40%-643.87K | -466.91%-440.64K | -3,350.31%-458.24K | ---471.28K | --45.05K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 72.25%-1.34M | 22.98%-593.17K | -205.98%-1.14M | -527.18%-9.29M | -3.32M | -1,654.63%-4.83M | -5,126.96%-770.19K | -1,559.45%-373.24K | -1.48M | -275.34K |
Capital expenditure reported | 94.93%-212.53K | 8.46%-591.43K | -89.37%-706.82K | -460.41%-8.29M | ---3.08M | -1,422.89%-4.19M | -75,821.27%-646.09K | ---373.24K | ---1.48M | ---275.34K |
Net PPE purchase and sale | 101.05%6.7K | 98.60%-1.74K | ---120.51K | -41,534.43%-1M | ---240.38K | ---638.07K | -793.85%-124.1K | --0 | ---2.41K | ---- |
Net business purchase and sale | ---1.13M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other investing changes | ---- | ---- | ---314.7K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 72.25%-1.34M | 22.98%-593.17K | -205.98%-1.14M | -527.18%-9.29M | ---3.32M | -1,654.63%-4.83M | -5,126.96%-770.19K | -1,559.45%-373.24K | ---1.48M | ---275.34K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 501.91%30.71K | -98.60%203.99K | 80.9K | 364.77%14.58M | -8.35K | -100.27%-7.64K | 14.59M | 0 | 3.14M | 2.81M |
Net issuance payments of debt | 92.25%-425 | ---5.33K | ---6.38K | 99.66%-11.77K | ---6.28K | ---5.49K | --0 | --0 | ---3.5M | ---- |
Net common stock issuance | ---- | --0 | ---- | 114.28%14.56M | ---- | ---- | --14.56M | ---- | --6.8M | --2.81M |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---- |
Proceeds from stock option exercised by employees | --31.5K | 647.25%215.78K | --89.25K | --28.88K | --0 | --0 | --28.88K | --0 | ---- | ---- |
Interest paid (cash flow from financing activities) | 83.05%-365 | ---1.45K | ---1.97K | 97.37%-4.22K | ---2.06K | ---2.15K | --0 | --0 | ---160.52K | ---- |
Net other financing activities | ---- | ---5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 501.91%30.71K | -98.60%203.99K | --80.9K | 364.77%14.58M | ---8.35K | -100.27%-7.64K | --14.59M | --0 | --3.14M | --2.81M |
Net cash flow | ||||||||||
Beginning cash position | -78.95%2.98M | 381.15%3.65M | 223.38%5.15M | 279.29%1.59M | --8.65M | 3,267.24%14.14M | 48.12%758.87K | --1.59M | --419.86K | --419.86K |
Current changes in cash | 70.79%-1.6M | -105.05%-675.9K | -79.48%-1.49M | 201.67%3.57M | ---3.5M | -312.35%-5.48M | 14,573.36%13.38M | -262.30%-831.48K | --1.18M | --2.58M |
Effect of exchange rate changes | -360.81%-17.51K | 101.01%37 | -188.44%-6.24K | -24.63%-13.99K | ---4.36K | -871.61%-3.8K | -13,984.62%-3.66K | -3,962.50%-2.16K | ---11.22K | ---391 |
End cash Position | -84.32%1.36M | -78.95%2.98M | 381.15%3.65M | 223.38%5.15M | --5.15M | 188.24%8.65M | 3,267.24%14.14M | 48.12%758.87K | --1.59M | --3M |
Free cash from | 90.56%-516.74K | 27.33%-879.89K | -51.37%-1.26M | -463.75%-11.01M | ---3.49M | -2,277.43%-5.47M | -1,209.54%-1.21M | -6,160.64%-831.48K | ---1.95M | ---230.29K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.